Raptor Pharmaceutical Inc.
7 Hamilton Landing
Suite 100
Novato
California
94949
United States
Tel: 415-408-6200
Fax: 415-382-8002
Website: http://raptorpharma.com/
Email: info@raptorpharma.com
188 articles about Raptor Pharmaceutical Inc.
-
Raptor Pharmaceutical Inc. To Hold Fourth Quarter And Full Year 2014 Financial Results Conference Call And Webcast On Thursday, February 26, 2015 At 4:30 P.M. ET
2/17/2015
-
Raptor Pharmaceutical Inc. Release: PROCYSBI To Receive New Treatment Award From Lysosomal Disease Network At The 11th Annual WORLD Symposium
2/10/2015
-
Raptor Pharmaceutical Inc. To Present At The 2015 Leerink Global Healthcare Conference
2/2/2015
-
Raptor Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1/20/2015
-
Raptor Pharmaceutical Inc. Appoints Krishna Polu, M.D. As Chief Medical Officer And Michael Smith As Chief Financial Officer
1/7/2015
-
Raptor Pharmaceutical Inc. Appoints Gregg Lapointe And Georges Gemayel To Board Of Directors
12/18/2014
-
Raptor Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
12/4/2014
-
Raptor Pharmaceutical Inc. To Present At The 26th Annual Piper Jaffray Healthcare Conference
11/18/2014
-
Raptor Pharmaceutical Inc. To Hold Third Quarter 2014 Financial Results Conference Call And Webcast On Thursday, November 6, At 4:30 P.M. ET
10/30/2014
-
Raptor Pharmaceutical Inc. Announces Management Changes
10/23/2014
-
Raptor Pharmaceutical Inc. To Present At Leerink Rare Disease Roundtable
9/23/2014
-
Raptor Pharmaceutical Inc. To Present At Upcoming Investor Conference In September
8/27/2014
-
Raptor Pharmaceutical Inc. Reports Second Quarter 2014 Financial Results And Provides Corporate Update
8/8/2014
-
Raptor Pharmaceutical Inc. To Present At Upcoming Investor Conference
8/6/2014
-
Raptor Pharmaceutical Inc. Receives Orphan Drug Designation For Cysteamine Bitartrate In Huntington's Disease From The European Commission
8/4/2014
-
Raptor Pharmaceutical Inc. To Hold Second Quarter 2014 Financial Results Webcast And Conference Call
7/29/2014
-
Raptor Pharmaceutical Inc. (RPTP) Names COO As Next CEO
7/8/2014
-
Novato's Raptor Pharmaceutical Inc. Reels In $70 Million
7/2/2014
-
Raptor Pharmaceutical Inc. Release: Data Published In Journal Of Pediatrics Demonstrated That PROCYSBI® Improved Quality Of Life And Preserved Kidney Function In Cystinosis Patients
6/24/2014
-
Raptor Pharmaceutical Inc. To Participate In Three Upcoming Investor Conferences In June
6/10/2014